Postoperative diagnosis of pulmonary actinomycosis in a patient with bronchiectasis ‒ a rare case
Open Access
- 30 December 2025
- journal article
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 1088-1092
Abstract
Introduction and aim. Pulmonary actinomycosis is a rare chronic infection caused by Actinomyces species, often mimicking tuberculosis, malignancy, or other chronic lung diseases both clinically and radiologically. These similarities frequently lead to diagnostic delays. We present a rare case of pulmonary actinomycosis in a patient with long-standing bronchiectasis who developed acute hemoptysis during anticoagulant therapy. Description of the case. A 59-year-old woman with a ten-year history of bronchiectasis and recent mechanical aortic valve replacement presented with persistent hemoptysis while on warfarin. Thoracic computed tomography revealed bronchiectatic changes and opacities in the right middle lobe. Bronchoscopy showed bloody, encrusted material, but no definitive diagnosis was made. Due to ongoing symptoms and radiological suspicion of malignancy, an urgent right middle lobectomy was performed. Histopathological analysis confirmed pulmonary actinomycosis, revealing filamentous organisms via PAS, Gram, and Grocott’s staining. Conclusion. This case highlights the importance of considering pulmonary actinomycosis in patients with bronchiectasis and unexplained hemoptysis, particularly when standard treatment fails. Surgical resection may be essential for both diagnosis and treatment. The case underscores how structural lung disease and anticoagulant use can reveal rare infections otherwise masked by chronic symptoms.Keywords
This publication has 11 references indexed in Scilit:
- Colloid Adenocarcinoma of the Lung With Concomitant Pulmonary Actinomycosis: A Case ReportRespirology Case Reports, 2025
- Pulmonary Actinomycosis in a 65-Year-Old Female with Poor Oral DentitionDiagnostics, 2024
- Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1)BMC Microbiology, 2024
- Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CTJournal of Nuclear Medicine, 2024
- Coexistence of COVID-19, Pseudomonas, and thoracic actinomycosis in a cystic bronchiectasis caseBMC Infectious Diseases, 2023
- The diagnosis and management of pulmonary actinomycosisJournal of Infection and Public Health, 2023
- Pulmonary Actinomyces graevenitzii Infection: Case Report and Review of the LiteratureFrontiers in Medicine, 2022
- Infección pulmonar por Actinomyces diagnosticada mediante ecobroncoscopia lineal. Correlación con los hallazgos histopatológicosOpen Respiratory Archives, 2022
- Enlightening clinical and therapeutic heterogeneity in thoracic actinomycosis: A review in bronchiectasis and non-bronchiectasis patientsPulmonary Pharmacology & Therapeutics, 2021
- Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis BronchiectasismSphere, 2018